Together, these studies suggest that disruption of CD47 signaling could potentially augment T cell cytotoxicity and infiltration into pancreatic tissues while inhibiting regulatory T cell-mediated protection against β-cell destruction in T1D (Figure 3). Here, CD47 is linked to type 1 diabetes mellitus.